Cargando…

MicroRNA-874 Functions as a Tumor Suppressor by Targeting Cancer/Testis Antigen HCA587/MAGE-C2

Cancer/testis antigen HCA587/MAGE-C2 has been considered as a tumor specific target for immunotherapy. It has been reported that HCA587/MAGE-C2 plays an active role in tumorigenesis by promoting the growth and survival of tumor cells. However, the regulation of HCA587/MAGE-C2 expression in cancer ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Xiao, Song, Wenjie, Wang, Ying, Wang, Jingjing, Li, Yan, Qian, Xiaoping, Pang, Xuewen, Zhang, Yu, Yin, Yanhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829551/ https://www.ncbi.nlm.nih.gov/pubmed/27076846 http://dx.doi.org/10.7150/jca.13674

Ejemplares similares

Induction of HCA587-Specific Antitumor Immunity with HCA587 Protein Formulated with CpG and ISCOM in Mice
por: Chen, Juanjuan, et al.
Publicado: (2012)

Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E
por: Hao, Jiaqing, et al.
Publicado: (2015)

Cancer/testis Antigen MAGEA3 Interacts with STAT1 and Remodels the Tumor Microenvironment
por: Wang, Ying, et al.
Publicado: (2018)

MicroRNA-587 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting Ribosomal Protein SA
por: Chen, Miao, et al.
Publicado: (2020)

MAGE cancer-testis antigens protect the mammalian germline under environmental stress
por: Fon Tacer, Klementina, et al.
Publicado: (2019)

Expression of cancer/testis antigens MAGE-A, MAGE-C1, GAGE and CTAG1B in benign and malignant thyroid diseases
por: Melo, Daniel Hardy, et al.
Publicado: (2017)

Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer
por: Mohsenzadegan, Monireh, et al.
Publicado: (2022)

Clinicopathological assessment of cancer/testis antigens NY-ESO-1 and MAGE-A4 in osteosarcoma
por: Hashimoto, Kazuhiko, et al.
Publicado: (2022)

Publisher Correction: Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer
por: Mohsenzadegan, Monireh, et al.
Publicado: (2022)

Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients
por: Freiberger, Sandra N., et al.
Publicado: (2022)

Cancer/Testis Antigen MAGE-C1/CT7: New Target for Multiple Myeloma Therapy
por: de Carvalho, Fabricio, et al.
Publicado: (2012)

Chromosomal Location of HCA1 and HCA2, Hybrid Chlorosis Genes in Rice
por: Ichitani, Katsuyuki, et al.
Publicado: (2012)

T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4
por: Coles, Charlotte H., et al.
Publicado: (2020)

Evaluation of MAGE-1 Cancer-Testis Antigen Expression in Invasive Breast Cancer and its Correlation with Prognostic Factors
por: Rastgoosalami, Mojtaba, et al.
Publicado: (2016)

MicroRNA-874 prohibits the proliferation and invasion of retinoblastoma cells by directly targeting metadherin
por: Zhang, Yongfeng, et al.
Publicado: (2022)

MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4
por: Marcar, Lynnette, et al.
Publicado: (2015)

Expression of MAGE‐A and NY‐ESO‐1 cancer/testis antigens is enriched in triple‐negative invasive breast cancers
por: Raghavendra, Ashwini, et al.
Publicado: (2018)

Expression and Prognostic Significance of Cancer/Testis Antigens, MAGE-E1, GAGE, and SOX-6, in Glioblastoma: An Immunohistochemistry Evaluation
por: Tabatabaei Yazdi, Seyed Abbas, et al.
Publicado: (2021)

MAGE-A Antigens and Cancer Immunotherapy
por: Zajac, Paul, et al.
Publicado: (2017)

An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients
por: Inaoka, Riguel J, et al.
Publicado: (2011)

microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway
por: Zhang, Yi, et al.
Publicado: (2018)

Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: a retrospective immunohistochemical study
por: Matković, Božica, et al.
Publicado: (2011)

Clinicopathological Assessment of Cancer/Testis Antigens NY-ESO-1 and MAGE-A4 in Highly Aggressive Soft Tissue Sarcomas
por: Hashimoto, Kazuhiko, et al.
Publicado: (2022)

Interferon-γ +874A/T Polymorphism and Hepatocellular Carcinoma Risk: A Meta-Analysis
por: Zhou, Huan, et al.
Publicado: (2015)

MicroRNA-874 inhibits cell proliferation and invasion by targeting cyclin-dependent kinase 9 in osteosarcoma
por: Tang, Wei, et al.
Publicado: (2018)

Immunohistochemical analysis of the expression of MAGE-A and NY-ESO-1 cancer/testis antigens in diffuse large B-cell testicular lymphoma
por: Hudolin, Tvrtko, et al.
Publicado: (2013)

Centrosomal Localisation of the Cancer/Testis (CT) Antigens NY-ESO-1 and MAGE-C1 Is Regulated by Proteasome Activity in Tumour Cells
por: Pagotto, Anna, et al.
Publicado: (2013)

MicroRNA-874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1
por: Liao, Haihong, et al.
Publicado: (2022)

MicroRNA miR-874-3p inhibits osteoporosis by targeting leptin (LEP)
por: Mei, Ling, et al.
Publicado: (2021)

Updates on Antiobesity Effect of Garcinia Origin (−)-HCA
por: Chuah, Li Oon, et al.
Publicado: (2013)

Hypertension-related, calcium-regulated gene (HCaRG/COMMD5) and kidney diseases: HCaRG accelerates tubular repair
por: Matsuda, Hiroyuki, et al.
Publicado: (2014)

The expression of the cancer testis antigen MAGE A4: A favorable prognostic biomarker in salivary gland carcinomas related to low tumor grading
por: Vital, Domenic, et al.
Publicado: (2018)

DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer
por: Zhang, Lei, et al.
Publicado: (2017)

MicroRNA-874 targets phosphomevalonate kinase and inhibits cancer cell growth via the mevalonate pathway
por: Aersilan, Alimasi, et al.
Publicado: (2022)

Cancer-testis antigen MAGE-C2/CT10 induces spontaneous CD4(+) and CD8(+) T-cell responses in multiple myeloma patients
por: Reinhard, H, et al.
Publicado: (2014)

Nanoparticles of Chitosan/Poly(D,L-Lactide-Co-Glycolide) Enhanced the Immune Responses of Haemonchus contortus HCA59 Antigen in Model Mice
por: Wang, Qiangqiang, et al.
Publicado: (2021)

HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma
por: Aref, Ahmed M, et al.
Publicado: (2014)

Evolutionary History of the Cancer Immunity Antigen MAGE Gene Family
por: Katsura, Yukako, et al.
Publicado: (2011)

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells
por: Mou, D-C, et al.
Publicado: (2002)

In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vi6f7u2ahn64j7veba9hbj912f